Varian

03/13/2026

Nearly five years ago, Varian and Siemens Healthineers came together with a shared mission to transform cancer care.

As we move forward as one, this post marks a transition — not an ending. Follow Siemens Healthineers to stay connected to the clinical insights, innovation milestones, and progress shaping the future of cancer care.

The momentum continues — and the next chapter is just getting started!

03/12/2026

More than half of all cancer patients benefit from radiotherapy, yet global access and capacity challenges remain. The field is rapidly advancing through adaptive treatment, integrated imaging, AI, and new indications that are reshaping what radiotherapy can achieve.

In a new Healthcare in Europe feature, Sasa Mutic shares how Varian is helping care teams deliver more precise and connected cancer care and how radiotherapy is expanding its impact for patients worldwide.

📖Read more:

Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the ledger, a new generation of technologies, from AI-driven adaptive planning to photon-counting CT, that are ...

03/11/2026

🌟 Practical insights and real-world experience with MRI in Radiation Therapy!

Last month, we hosted another engaging MRInsights in RT virtual user meeting, featuring two experienced medical physicists who shared their clinical perspectives and practical examples from their daily use of MRI in radiation therapy. Their presentations highlighted how MRI is being integrated into routine workflows and supporting the adoption of MRI in RT.

A big thank you to our excellent speakers and to our active community for the great discussions and strong participation.

🎥 Couldn’t join us live?

The recordings are now available – take this opportunity to explore practical examples and hear directly from peers on how MRI is being integrated into RT workflows worldwide. https://www.siemens-healthineers.com/radiotherapy/mri-for-rt/mrinsights-rt?stc=wwhc249694

03/10/2026

Congratulations to Hospital Aranda de la Parra on the inauguration of a new TrueBeam linear accelerator at its Centro Especializado en Oncología.

Equipped with HyperSight and HyperArc technologies, this installation marks the next evolution in the hospital’s goals for delivering advanced, patient‑centered cancer care in the region.

By continuing to invest in modern radiotherapy technology and specialized infrastructure, and by collaborating with regional and public health partners, Hospital Aranda de la Parra reinforces its long‑standing role in supporting access to cancer care for patients across the Guanajuato region of Mexico.

02/23/2026

Congratulations to Sanatorio Americano in Montevideo, the first clinic in Southern Latin America to bring Ethos adaptive radiotherapy to their patients — a major step forward in improving local access to this advanced treatment.

The hospital plans to treat its first adaptive radiotherapy patient in March 2026, delivering personalized care to support treatments such as prostate, pancreatic, and liver SBRT, alongside treatment for cervical and bladder cancer.

Congratulations to Sanatorio Americano on this important achievement. We're proud to support your team in advancing patient care across Montevideo.

02/20/2026

02/12/2026

Driving smarter decisions in radiation oncology! HyperSight imaging solution delivers larger, sharper, and faster in-room images to enhance radiotherapy precision and better spare healthy tissue.

There has always been interest in understanding the financial impact of HyperSight, balancing its initial cost with the long-term value it brings.

The Erasmus MC team has published an insightful study in Radiotherapy and Oncology (The Green Journal) on a HyperSight break-even point calculation—a critical step in evaluating the economic and clinical viability of advanced imaging solutions in treatment workflows.

This research provides:
✅ A robust framework for calculating break-even points for HyperSight implementation
✅ Key considerations for balancing cost, efficiency, and patient outcomes
✅ Evidence to support informed decision-making for technology adoption in oncology

Why this matters: As healthcare systems strive for value-based care, understanding the financial and operational impact of innovations like HyperSight ensures sustainable progress.

📄 Read the full publication here: https://bit.ly/4txTYIN
Cost-benefit analysis of advanced CBCT imaging: Incremental costs and savings. Larrotta-Castillo, Diego A. et al. Radiotherapy and Oncology, Volume 211, 111106

👏 Congratulations to the Erasmus MC team for leading the way in combining clinical excellence with economic insight!

QR70003427

02/10/2026

Continuing the Conversation: Supporting Patients Beyond Treatment

Our recent segment on The Balancing Act explores how modern radiotherapy helps place patients at the center of cancer care by reducing anxiety, providing clarity, and ensuring support throughout the treatment journey.

Featuring expert insights and a real patient perspective, the segment offers guidance and reassurance for those navigating a cancer diagnosis; reminding them that care today is backed by innovation, compassion, and hope.

📺 Watch the segment: https://bit.ly/49RL4gq
🔗 Learn more about radiotherapy: https://cancercare.siemens-healthineers.com/

QR700033838

02/04/2026

Every cancer journey is shaped by individual experiences, challenges, and moments of courage. On World Cancer Day, we pause to honor those stories—and the people behind them.

This year’s theme, , is a reminder that while no two experiences with cancer are the same, we can all contribute to a future where no one has to live with the fear of the disease.

We invite you to reflect with us: Whose story comes to mind when you imagine a world where cancer no longer casts such a long shadow?

01/22/2026

Now Airing: Varian on The Balancing Act

We’re proud to be featured on The Balancing Act, a national lifestyle and health program airing on Lifetime, to help raise awareness about the vital role of modern radiotherapy in cancer care.

This educational segment explores how advances in precision radiotherapy are empowering care teams to deliver more targeted treatments while enhancing the patient experience. It also offers expert insights and a patient perspective to demystify what radiotherapy is and what patients can expect.

At Varian, we’re committed to advancing cancer care through innovation, collaboration, and education so patients and families feel informed and supported at every step of the journey.

📺 Watch the segment: https://bit.ly/49RL4gq
🔗 Learn more about radiotherapy: www.varian.com

QR700033838

01/07/2026

Radiation therapy has long been central to cancer care — with 50–70% of patients requiring it during their journey.* But at this year’s meeting, the focus extended far beyond oncology. https://bit.ly/3NxWxdj

Varian’s leadership in the role of radiation therapy for non-cancerous diseases was evident across sessions, from investigator‑led studies to advisory board contributions at the ASTRO Presidential Symposium.

Radiotherapy is being rediscovered, redefined, and expanded — opening new doors for patients and providers alike.

*Lancet Global Health 2024

QR700032951

12/30/2025

Investing in global health is a long-term commitment—and we’re in it for the long haul.

While our collaboration in Kenya with Moi Teaching and Referral Hospital and IU Health has made incredible strides in expanding access, we know the journey is far from over.

Through education, empowerment, and the strengthening of local expertise, the community is building an ecosystem that will enable it to thrive for generations to come.

Together, we’re building a future where healthcare is accessible to everyone, everywhere, and sustained by shared commitment. https://cbsn.ws/3KHLLjY

QR700031713